Approved in May 2019, granted to FoldRx, a subsidiary of Pfizer.
Kevin Luong, PharmD Candidate 2021
Advertisement
Articles by Kevin Luong, PharmD Candidate 2021
Advertisement
Latest Updated Articles
New Drug Review: Tafamidis Meglumine for CardiomyopathyPublished: October 24th 2019 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
First OTC Pill for Birth Control Significantly Advances Health Equity
2
Survey Shows Significant Gaps in Understanding of Shared Decision-Making
3
Bepirovirsen Meets Primary End Point for Functional Cure Rate of Hepatitis B
4
CPAs Give Community Pharmacists More Active Roles in Health Care
5